ArticleNPJ breast cancer2023

ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation.

Rosemary J Huggins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.